EUVIMEDEUVIMED entdecken
Crossref

Synthesis, in Vitro Anticancer Evaluation, and Structure–Activity Relationships of Novel C4- and C7-Aryl-Substituted Pyrazolo[1,5-a][1,3,5]triazines

Stepan G. Pilyo, Bohdan A. Demydchuk, Serhii V. Popilnichenko, Victor V. Zhirnov, Svitlana V. Shishkina

SynOpen · 01.06.2026 · 10 (02) · 172-184

DOI: 10.1055/a-2873-3153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SynOpen, erschienen am 01.06.2026. Verfasst von Stepan G. Pilyo und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of pyrazolo[1,5-a][1,3,5]triazine derivatives is synthesized and characterized to assess their anticancer potential. Among the tested compounds, 2-(dichloromethyl)-7-(4-methylphenyl)-4-(pyridin-3-yl)pyrazole[1,5-a][1,3,5]triazine (4) and its analogue 2-(dichloromethyl)-7-phenyl-4-pyridin-3-ylpyrazolo[1,5-a][1,3,5]triazine (7) showed the highest activity. In contrast to the other derivatives, which displayed only weak growth-inhibitory effects, compounds 4 and 7 contain a 3-pyridyl substituent at the C4 position of the pyrazolotriazine scaffold. Both compounds demonstrated broad-spectrum antiproliferative activity in the NCI-60 human cancer cell line panel. Compound 4 exhibited GI50 values of 0.32–2.22 μM, with the highest potency against NSCLC, breast cancer, and leukemia cell lines. Compound 7 was even more potent, showing GI50 values of 0.03–3.04 μM and selective activity against renal cancer, breast cancer, and leukemia cell lines. In most cases, LC50 values exceeded 100 μM, indicating low overall cytotoxicity despite strong growth inhibition. ADMET predictions suggested favorable drug-like properties, including high intestinal absorption, CNS permeability, weak P-gp substrate behavior, and probable P-gp inhibition. Structure–activity relationship (SAR) analysis identified the 2-dichloromethyl group as a key determinant of activity, while the C4 substituent effect followed the order 3-pyridyl > 2-methylphenyl ≈ 2-fluorophenyl > phenyl ≈ 4-tert-butyl.

Zitieren

APA

Pilyo, S. G., Demydchuk, B. A., Popilnichenko, S. V., Zhirnov, V. V., & Shishkina, S. V. (2026). Synthesis, in Vitro Anticancer Evaluation, and Structure–Activity Relationships of Novel C4- and C7-Aryl-Substituted Pyrazolo[1,5-a][1,3,5]triazines. SynOpen, 10(02), 172-184. https://doi.org/10.1055/a-2873-3153

Vancouver

Pilyo SG, Demydchuk BA, Popilnichenko SV, Zhirnov VV, Shishkina SV. Synthesis, in Vitro Anticancer Evaluation, and Structure–Activity Relationships of Novel C4- and C7-Aryl-Substituted Pyrazolo[1,5-a][1,3,5]triazines. SynOpen. 2026;10(02):172-184. doi:10.1055/a-2873-3153

BibTeX
@article{Pilyo2026,
  author = {Pilyo, Stepan G. and Demydchuk, Bohdan A. and Popilnichenko, Serhii V. and Zhirnov, Victor V. and Shishkina, Svitlana V.},
  title = {Synthesis, in Vitro Anticancer Evaluation, and Structure–Activity Relationships of Novel C4- and C7-Aryl-Substituted Pyrazolo[1,5-a][1,3,5]triazines},
  journal = {SynOpen},
  year = {2026},
  volume = {10},
  number = {02},
  pages = {172--184},
  doi = {10.1055/a-2873-3153}
}
Kostenlos starten →